Changes

Other Names: Amandier Indien, Amandier Tropical, Arjan des Indes, Arjuna, Axjun Argun, Badamier, Badamier Géant, Baheda, Bahera, Bala Harade, Balera, Behada, Beleric Myrobalan, Belleric Myrobalan, Belliric Myrobalan, Bhibitaki, Bibhitak, Bibitaki, Carambole Marron, Chebulic Myrobalan, Hara, Harad, Harada, Haritaki, He Zi, Hirala, Indian Almond, Kalidruma, Karshaphala, Myrobalan, Myrobolan Bellirique, Myrobolan Chébule, Terminalia arjuna, Terminalia bellirica, Terminalia chebula, Terminalia chebulic, Tropical Almond, Vibhitaki.<br> Terminalia arjuna is an evergreen plant native to India that reaches up to 100 feet. The white-to-pinkish-gray bark of the arjuna is one of the most frequently prescribed herbs in ayurvedic medicine, mostly for heart health. Clinical studies are verifying that the plant may indeed benefit patients with coronary artery disease, but they're also discovering that arjuna may have other health benefits.

* Terminalia arjuna is POSSIBLY SAFE when used short-term (for three months or less). But don’t use it without medical supervision. It might affect your heart.

*Not enough is known about the safety of Terminalia bellerica and Terminalia chebula. It’s best to avoid use until more is known.

*Pregnancy and breast-feeding: There is some evidence that Terminalia arjuna is POSSIBLY UNSAFE during pregnancy. The safety of the other two species during pregnancy is unknown. It’s best to avoid using any terminalia species.

*There isn’t enough information about the safety of terminalia during breast-feeding. Stay on the safe side and avoid use.

* In traditional Ayurvedic medicine, Terminalia arjuna has been used to balance the three “humors”: kapha, pitta, and vata. It has also been used for asthma, bile duct disorders, scorpion stings, and poisonings.

*The bark of Terminalia arjuna has been used in India for more than 3000 years, primarily as a heart remedy. An Indian physician named Vagbhata has been credited as the first to use this product for heart conditions in the seventh century A.D. Research on terminalia has been going on since the 1930s, but studies have provided mixed results. Its role, if any, in heart disease still remains uncertain.